FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to clinical pharmacology, and can be used for differentiated choice of pharmacotherapy of back pain with underlying dorsopathy in operators. Cytochrome P 450 CYP2C9 gene polymorphism is determined. If observing CYP2C9*1/*2 or *2/*2 genotypes, meloxicam 15 mg/day in tablet form is prescribed for 10 days for the treatment of pain syndrome. If genotype CYP2C9*1/*1 is detected, diclofenac is used in dosage 75-100 mg/day in tablet form for 10 days.
EFFECT: method provides selecting an individualized drug therapy regimen for treating chronic pain syndrome in operators by determining cytochrome P 450 CYP2C9 gene polymorphism.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIATED CHOICE OF PHARMACOTHERAPY OF ARTERIAL HYPERTENSION WITH UNDERLYING DORSOPATHY IN OPERATORS | 2024 |
|
RU2826094C1 |
METHOD FOR IMPROVING DRUG USE SAFETY IN TREATING PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME | 2018 |
|
RU2690522C1 |
METHOD FOR CHOOSING STARTING ANALGESIC DRUGS IN THE POSTOPERATIVE PERIOD AFTER CARDIAC SURGERY | 2021 |
|
RU2774227C1 |
METHOD OF HEALTH ASSESSMENT OF OPERATORS | 2008 |
|
RU2364333C1 |
METHOD FOR PSYCHOMOTOR ACTION SPEED INCREASE WITH ANXIOLYTIC AFOBAZOL | 2013 |
|
RU2528110C1 |
METHOD FOR CHOOSING THE STARTING SCHEME OF POSTOPERATIVE ANESTHESIA IN PATIENTS AFTER VIDEOLAPAROSCOPIC CHOLECYSTECTOMY | 2021 |
|
RU2779003C1 |
METHOD FOR SELECTING START ANTIHYPERTENSIVE THERAPY WITH ANGIOTENSIN II RECEPTOR BLOCKERS IN PATIENTS WITH NEWLY DIAGNOSED DEGREE 1-2 ARTERIAL HYPERTENSION | 2024 |
|
RU2838951C1 |
METHOD FOR SELECTION OF PERINDOPRIL DOSAGE FORPATIENTS WITH ISCHEMIC HEART DISEASE ON BACKGROUND OF ARTERIAL HYPERTENSION | 2016 |
|
RU2642284C1 |
METHOD FOR DEGENERATIVE-DYSTROPHIC SPINE DISEASES (DORSOPATHIES) TREATMENT | 2016 |
|
RU2640001C1 |
METHOD FOR IMPROVING QUALITY OF LIFE AND INCREASING PROFESSIONAL COMPETENCE IN PATIENTS WITH OSTEOARTHROSIS FULFILLING DRIVING AND SUPERVISION FUNCTIONS | 2012 |
|
RU2499595C1 |
Authors
Dates
2025-05-23—Published
2024-03-01—Filed